Table 2 Patient characteristics.

From: Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes

Participant number

Age

Gender

BMI

Years since diagnosis

Therapy

Total units of insulin injection per day

Total units of insulin injection per day/BW (kg)

HbA1c (%) of baseline

Fasting serum CPR (ng/ml)

1

46.4

Female

18.1

1.3

MDI

20.0

0.43

7.4

0.277

2

74.2

Female

14.9

13.3

MDI

27.0

0.86

9.5

< 0.01

3

61.7

Male

29.7

19.3

CSII

48.2

0.66

9.3

< 0.01

4

70.7

Female

22.0

25.8

CSII

51.6

1.04

7.4

< 0.01

5

34.2

Female

25.0

1.2

CSII

48.0

0.82

6.5

< 0.01

6

70.5

Female

20.6

30.8

MDI

32.0

0.69

6.4

< 0.01

7

70.9

Female

20.3

23.8

MDI

8.0

0.18

6.3

1.21

8

55.2

Female

20.3

0.7

MDI

23.0

0.44

6.7

1.13

9

38.4

Female

23.6

3.8

CSII

25.5

0.39

8.6

< 0.01

10

30.5

Male

27.9

14.8

CSII

50.2

0.63

11.5

< 0.01

11

32.3

Female

21.0

0.6

CSII

32.5

0.76

7.5

< 0.01

12

62.3

Male

19.6

1.4

MDI

33.0

0.53

7.2

0.311

13

39.0

Female

18.9

0.9

CSII

34.0

0.74

6.2

0.409

14

42.6

Male

27.5

9.0

MDI

53.0

0.65

7.2

< 0.01

15

43.2

Male

23.0

3.6

CSII

30.4

0.45

7.7

0.318

16

63.1

Female

16.8

4.0

MDI

17.0

0.42

7.3

0.064

17

53.1

Male

23.2

1.9

MDI

15.0

0.19

6.7

0.931

18

75.8

Female

21.1

5.0

MDI

18.0

0.37

8.2

0.285

19

45.3

Female

19.1

6.3

CSII

26.0

0.55

7.2

0.030

Total or mean ± SD

53.1 ± 15.2

Female: 13, Male: 6

21.7 ± 3.8

8.8 ± 9.6

MDI: 10, CSII: 9

31.2 ± 13.5

0.57 ± 0.22

7.6 ± 1.3

0.261 ± 0.397a

  1. BMI body mass index, BW body weight, CPR C-peptide immunoreactivity, CSII continuous subcutaneous insulin infusion, MDI multiple dose insulin injection.
  2. aThe values of serum CPR “ < 0.01” were considered as 0 and calculated. Fasting CPR was measured on at least three different dates and the value on the day closest to the baseline date were adopted.